These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35546765)

  • 21. Advances in epigenetic biomarker research in colorectal cancer.
    Wang X; Kuang YY; Hu XT
    World J Gastroenterol; 2014 Apr; 20(15):4276-87. PubMed ID: 24764665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of epigenetics in colorectal cancer.
    Coppedè F
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers.
    Ponomaryova AA; Rykova EY; Solovyova AI; Tarasova AS; Kostromitsky DN; Dobrodeev AY; Afanasiev SA; Cherdyntseva NV
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of osteoprotegerin expression as a novel biomarker for colorectal carcinoma.
    Kim HS; Yoon G; Do SI; Kim SJ; Kim YW
    Oncotarget; 2016 Mar; 7(12):15187-99. PubMed ID: 26942563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer.
    Müller D; Győrffy B
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188722. PubMed ID: 35307512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetics and its therapeutic potential in colorectal cancer.
    Oryani MA; Tavasoli A; Ghalavand MA; Ashtiani RZ; Rezaee A; Mahmoudi R; Golvari H; Owrangi S; Soleymani-Goloujeh M
    Epigenomics; 2022 Jun; 14(11):683-697. PubMed ID: 35473313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Methylation Biomarkers for Colorectal Cancer Prognosis.
    Gutierrez A; Demond H; Brebi P; Ili CG
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance.
    Zhao N; Lai C; Wang Y; Dai S; Gu H
    Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189096. PubMed ID: 38499079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
    Gao X; Yang J
    DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
    Coppedè F
    Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
    Kasprzak A; Adamek A
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic biomarkers in colorectal cancer diagnostics.
    Rawson JB; Bapat B
    Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetics and colorectal cancer.
    Lao VV; Grady WM
    Nat Rev Gastroenterol Hepatol; 2011 Oct; 8(12):686-700. PubMed ID: 22009203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNAs in colorectal cancer.
    Xie X; Tang B; Xiao YF; Xie R; Li BS; Dong H; Zhou JY; Yang SM
    Oncotarget; 2016 Feb; 7(5):5226-39. PubMed ID: 26637808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA Methylome Signature and Their Functional Roles in Colorectal Cancer Diagnosis, Prognosis, and Chemoresistance.
    Baharudin R; Rus Bakarurraini NQ; Ismail I; Lee LH; Ab Mutalib NS
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New trends in molecular and cellular biomarker discovery for colorectal cancer.
    Aghagolzadeh P; Radpour R
    World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
    Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
    World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating proteomics and transcriptomics for the identification of potential targets in early colorectal cancer.
    Yang W; Shi J; Zhou Y; Liu T; Zhan F; Zhang K; Liu N
    Int J Oncol; 2019 Aug; 55(2):439-450. PubMed ID: 31268166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.
    Toiyama Y; Okugawa Y; Goel A
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):43-57. PubMed ID: 25128828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.